高级检索
当前位置: 首页 > 详情页

Identifying the insulin resistance index in nondiabetic Chinese subjects

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Dept Endocrinol, Beijing Tongren Hosp, Beijing 100730, Peoples R China [2]Capital Med Univ, Dept Endocrinol, Beijing Luhe Hosp, Beijing, Peoples R China [3]Dong Jiao Min Xiang, Beijing Key Lab Diabet Prevent & Res, Beijing, Peoples R China [4]Beijing Sijiqing Hosp, Dept Internal Med, Beijing, Peoples R China
出处:
ISSN:

关键词: anthropometric measurement BMI cut-off points HOMA-IR insulin resistance

摘要:
In the present study, the performance of anthropometric parameters, lipid and glucose indexes, and the combination of anthropometric parameters with the TyG (triglycerides x fasting plasma glucose) metabolic index, was compared in detecting insulin resistance (IR) to evaluate the optimal cut-off points in nondiabetic Chinese individuals. A total of 1067 nondiabetics underwent oral glucose tolerance test, blood lipid, and fasting insulin measurements. The clinical usefulness of various parameters- body mass index (BMI), waist circumference (WC), TyG, triglycerides/ high density lipoprotein cholesterol ratio, and TyG with adiposity status (TyG-BMI [TyG x BMI] and TyG-WC)-was analyzed to identify IR. Spearman correlation and receiver-operating characteristic curve analyses were used to compare the predictive efficacy of different indicators. All indicators showed a positive correlation with IR in both normal glucose and all subjects. However, the correlation between BMI and homeostasis model assessment of IR index was higher than other indicators as assessed by Spearman correlation test (P<.05). Furthermore, BMI and TyG-BMI were better indicators than others as determined by comparing the area under the receiver-operating characteristics curves (P<.05) in detecting IR. BMI is a simple and accurate measure for detecting IR in Chinese subjects. The 27kg/m(2) threshold was the optimal BMI cut-off point for detecting IR in both normal glucose and all glucose categories subjects.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 医学:内科
JCR分区:
出版当年[2018]版:
Q2 MEDICINE, GENERAL & INTERNAL
最新[2023]版:
Q2 MEDICINE, GENERAL & INTERNAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Capital Med Univ, Dept Endocrinol, Beijing Tongren Hosp, Beijing 100730, Peoples R China [3]Dong Jiao Min Xiang, Beijing Key Lab Diabet Prevent & Res, Beijing, Peoples R China [4]Beijing Sijiqing Hosp, Dept Internal Med, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Capital Med Univ, Dept Endocrinol, Beijing Tongren Hosp, Beijing 100730, Peoples R China [3]Dong Jiao Min Xiang, Beijing Key Lab Diabet Prevent & Res, Beijing, Peoples R China [*1]Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)